DiaSorin has patented methods and compositions for nucleic acid amplification, detection, and genotyping. The patent involves a method for amplifying target nucleic acid using specific primers, a reporter, and a capture complex. This innovation could advance molecular diagnostic techniques. GlobalData’s report on DiaSorin gives a 360-degree view of the company including its patenting strategy. Buy the report here.

Smarter leaders trust GlobalData


Premium Insights DiaSorin SpA - Company Profile

Buy the Report

Premium Insights

The gold standard of business intelligence.

Find out more

According to GlobalData’s company profile on DiaSorin, Microfluidic devices was a key innovation area identified from patents. DiaSorin's grant share as of February 2024 was 63%. Grant share is based on the ratio of number of grants to total number of patents.

Nucleic acid amplification method using specific primers and tags

Source: United States Patent and Trademark Office (USPTO). Credit: DiaSorin SpA

A recently granted patent (Publication Number: US11884965B2) discloses a method for amplifying a target nucleic acid. The method involves providing a first primer pair with specific sequences, a reporter, and a capture complex attached to a solid support. The target nucleic acid is then amplified by combining the first primer pair, the reporter, the capture complex, and a sample containing the target nucleic acid under suitable conditions for amplification.

Furthermore, the method includes additional steps such as hybridizing the amplified nucleic acid to the anti-tag sequence of the capture complex, detecting the amplified nucleic acid, and potentially amplifying multiple target nucleic acids simultaneously by combining different primer pairs. The use of distinguishable capture complexes allows for spatially or optically distinguishable results, enhancing the efficiency and accuracy of the amplification process. Overall, this patented method offers a comprehensive approach to nucleic acid amplification with various applications in research, diagnostics, and other fields requiring precise nucleic acid analysis.

To know more about GlobalData’s detailed insights on DiaSorin, buy the report here.

Premium Insights


The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.


GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.

GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies across the world’s largest industries.